Follow The Filings

PTGX position history

The shares of Protagonist Therapeutics (PTGX) that POLEN CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q2: 15,999 shares, $884K, <0.01% of portfolio, New
  2. 2025 Q3: 20,325 shares, $1.4M, <0.01% of portfolio, Add +27.0%
  3. 2025 Q4: 20,349 shares, $1.8M, <0.01% of portfolio, Add +0.1%
  4. 2026 Q1: 24,337 shares, $2.6M, 0.02% of portfolio, Add +19.6%
  5. 2026 Q2: 22,651 shares, $2.8M, 0.02% of portfolio, Reduce −6.9%
  6. 2026 Q3: 20,963 shares, $3M, 0.03% of portfolio, Reduce −7.5%
Holdings date Value % of holdings Shares Filing date All 13F holders